FDA Adverse Event Malfunction Summary report: N

REMUNITY PUMP FOR REMODULIN (TREPROSTINIL) INJECTION

MDR report key: 24339884 · Received February 13, 2026

Report

Report Number
3016798778-2026-00023
Event Type
Malfunction
Date Received
February 13, 2026
Date of Event
December 18, 2025
Report Date
February 13, 2026
Manufacturer
MILLYARD ADVANCED MEDICAL PRODUCTS, LLC
Product Code
QJY
UDI-DI
00850017421035
PMA / PMN Number
K202690
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

BASED ON THE INFORMATION AVAILABLE FOR ASSESSMENT, A RELATIONSHIP BETWEEN THE REMUNITY SYSTEM AND THE PATIENT'S SYMPTOMS COULD NOT BE CONFIRMED. EFFORTS TO OBTAIN ADDITIONAL INFORMATION FROM CVS SPECIALTY PHARMACY WERE UNSUCCESSFUL. AT THE TIME OF THIS REPORT, NO COMPONENTS OR ADDITIONAL INFORMATION HAVE BEEN PROVIDED TO MILLYARD ADVANCED MEDICAL PRODUCTS, LLC, FOR FURTHER INVESTIGATION.

Description of Event or Problem · 0

AN INITIAL EVENT NOTIFICATION WAS RECEIVED BY UNITED THERAPEUTICS DRUG SAFETY ON 16-JAN-2026 FROM CVS SPECIALTY PHARMACY, AND FORWARDED TO MILLYARD ADVANCED MEDICAL PRODUCTS, LLC ON 17-JAN-2026. IT WAS REPORTED THAT THE PATIENT HAD PULLED OUT THEIR INFUSION SITE AND AFTER PLACING A NEW SITE, THE PATIENT EXPERIENCED SEVERE VOMITING, DIARRHEA, AND FLUSHING. THE PATIENT WAS SUBSEQUENTLY HOSPITALIZED ON (B)(6) 2025. IT WAS REPORTED THAT THE PATIENT HAD POSSIBLY RECEIVED A BOLUS DOSE FROM THEIR OLD SITE; HOWEVER, NO FURTHER INFORMATION REGARDING THIS ALLEGATION WAS PROVIDED. THE PATIENT WAS ULTIMATELY DISCHARGED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
394785 REMUNITY PUMP FOR REMODULIN (TREPROSTINIL) INJECTION INFUSION PUMP QJY MILLYARD ADVANCED MEDICAL PRODUCTS, LLC DKPI-11042-001 00850017421035

Patients

Seq Age Sex Outcome Treatment
1 76 YR Female Hospitalization